Short report
Mesenteric infarction due to combined protein C deficiency and
prothrombin 20210 defects
C J Mainwaringa, M Makrisa, W E G Thomasb, K K Hamptona, F E Prestona
a Royal
Hallamshire Hospital, Sheffield, UK Department
of Haematology, b Department of
Surgery
Correspondence to: Dr C J Mainwaring, Department of Haematology, Royal Hampshire County Hospital, Romsey Road, Winchester SO22 5DG, UK
Accepted 14 June 1999
The prothrombin gene mutation, 20210A, a guanine to
adenine substitution at nucleotide position 20210, has recently been
described as an additional risk factor for venous thromboembolic
disease. We describe the case of a patient with combined heterozygous
prothrombin 20210A mutation and type 1 protein C deficiency who
presented with massive mesenteric venous infarction of his small bowel
and survived following the use of protein C concentrate and extensive small bowel resection.
Keywords: mesenteric venous infarction; protein C deficiency; prothrombin 20210A
© 1999 by The Fellowship of Postgraduate Medicine
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
